Segregation of these patients into KRT19-high and low expression groups did not reveal significant relationship with clinicopathological parameters of sex, age, tumor size, location, but noticeably associated with tumor grading, TNM staging (Table 5). The gene discussed is KRT19; the disease is neoplasm.